Affiliations 

  • 1 Division of Biomedical Science, School of Pharmacy, University of Nottingham Malaysia, Semenyih, 43500 Selangor, Malaysia
  • 2 Integrative Medical Sciences, Northeast Ohio Medical University, 4209 St. Rt. 44, P.O. Box 95, Rootstown, OH P.O. Box 95, USA
  • 3 The Pharmacogenomics Laboratory, Department of Pharmacology, University of Malaya, 50603 Kuala Lumpur, Malaysia
  • 4 Institute of Medical Science Technology, Universiti Kuala Lumpur, Kajang, 43000 Selangor, Malaysia
Can J Physiol Pharmacol, 2021 Sep;99(9):827-838.
PMID: 33529092 DOI: 10.1139/cjpp-2020-0581

Abstract

Cardiovascular disease (CVD) is among the leading causes of death worldwide. MicroRNAs (miRNAs), regulatory molecules that repress protein expression, have attracted considerable attention in CVD research. The vasculature plays a big role in CVD development and progression and dysregulation of vascular cells underlies the root of many vascular diseases. This review provides a brief introduction of the biogenesis of miRNAs and exosomes, followed by overview of the regulatory mechanisms of miRNAs in vascular smooth muscle cells (VSMCs) intracellular signaling during phenotypic switching, senescence, calcification, and neointimal hyperplasia. Evidence of extracellular signaling of VSMCs and other cells via exosomal and circulating miRNAs is also presented. Lastly, current drawbacks and limitations of miRNA studies in CVD research and potential ways to overcome these disadvantages are discussed in detail. In-depth understanding of VSMC regulation via miRNAs will add substantial knowledge and advance research in diagnosis, disease progression, and (or) miRNA-derived therapeutic approaches in CVD research.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.